BDR Pharma develops medicines against cancer cell replication
Mumbai: BDR Pharma, a generic company, announces that Cabozantinib can be launched, which can treat metastatic meduller thyroid, advanced renal cell carcinoma and carcinoma of the hepatocellular cell. Cabozantinib is prescribed as a second-line treatment fo...
15 September, 2021
Read more